1. Home
  2. Advocacy
  3. Latest News and Practice Data
  4. Did You Know? Some Pathologist Quality Measure Data is Now Publicly Available

The CMS reports Quality Payment Program (QPP) performance data for doctors and groups in two venues: Medicare Care Compare Doctors and Clinicians profile pages and the Provider Data Catalog.

The CMS recently made available 2021 performance data, including MIPS eligible groups’ final scores and scores on certain quality measures. Starting with 2021, performance data for 8 pathology quality measures is available at the individual pathologist level in the Provider Data Catalog, which is downloadable by anyone. The measures are:

  • QID 249: Barrett’s Esophagus
  • QID 250: Radical Prostatectomy Reporting
  • QID 395: Lung Cancer Reporting (Biopsy/Cytology Specimens)
  • QID 396: Lung Cancer Reporting (Resection Specimens)
  • QID 397: Melanoma Reporting
  • QID 440: Skin Cancer: Biopsy Reporting Time Pathologist to Clinician
  • CAP 22: Turnaround Time (TAT) - Biopsies
  • CAP 28: Helicobacter pylori Status and Turnaround Time

Additionally, performance information for groups reporting CAP 22 or CAP 28 is available on Doctors and Clinicians profile pages. This is not yet at the individual performance level, like the provider data catalog. The CMS reserves the right to add performance information about quality measures once the measures meet statistical public reporting standards.

The CMS encourages Medicare beneficiaries and other patients to use performance information on Doctors and Clinicians profile pages to assist with decisions about which doctor or practice to go to. Publicly available data, including data in the Provider Data Catalog, can also be used by researchers examining trends in health care quality.

For additional information, please visit the CMS’ Care Compare website or email QPP@cms.hhs.gov.

Most Recent Content

  1. January 27, 2026
  2. Bill to stop Medicare cuts to lab tests moves to the Senate
  3. Lawmakers press insurers on health care affordability
  4. Virginia bill targets delays to lab test results
  5. CMS takes measures to improve Medicare Advantage
  6. View All